Markedsdata leveret af TwelveData og Morningstar
Tempus AI, Inc. Class A Common Stock represents ownership in Tempus AI, a healthcare technology company focused on precision medicine and AI-enabled diagnostics. Tempus AI develops products and services that combine clinical data, molecular testing, and software tools to help physicians, researchers, and life sciences organizations make more informed decisions. Its current business centers on genomics, data and services, and AI applications, including tools that support oncology, cardiology, radiology, and other clinical areas. The company also provides platforms for data analysis, diagnostic interpretation, and research workflows, making it an important participant in the broader healthcare data and personalized medicine market. Tempus AI is based in Chicago, Illinois, and operates as a public company in the healthcare technology sector.